Stock OUTLOOK THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Analyst Reco. OUTLOOK THERAPEUTICS, INC. Nasdaq

Equities

US68235M1053

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
BTIG Upgrades Outlook Therapeutics to Buy From Neutral, Price Target at $50
MT
Chardan Upgrades Outlook Therapeutics to Buy From Neutral, $3 Price Target; Says Risk/Reward is Favorable for Lytenava BLA Resubmission
MT
Chardan Upgrades Outlook Therapeutics to Buy From Neutral, $3 Price Target
MT
Guggenheim Upgrades Outlook Therapeutics to Buy From Neutral, Sets Price Target at $2
MT
Brookline Capital Upgrades Outlook Therapeutics to Buy From Hold, Price Target is $1.57
MT
Capital One Upgrades Outlook Therapeutics to Overweight From Equalweight With $5 Price Target
MT
Chardan Downgrades Outlook Therapeutics to Neutral From Buy
MT
HC Wainwright Downgrades Outlook Therapeutics to Neutral From Buy, Price Target is $1
MT
Brookline Capital Downgrades Outlook Therapeutics to Hold From Buy
MT
Cantor Fitzgerald Downgrades Outlook Therapeutics to Neutral From Overweight, Adjusts Price Target to $1 From $4.50
MT
BTIG Downgrades Outlook Therapeutics to Neutral From Buy
MT
Capital One Initiates Outlook Therapeutics With Overweight Rating, $5 Price Target
MT
Guggenheim Initiates Outlook Therapeutics at Buy With $5 Price Target
MT
Cantor Fitzgerald Initiates Outlook Therapeutics at Overweight With $4 Price Target
MT
HC Wainwright Adjusts Price Target on Outlook Therapeutics to $5 From $6, Maintains Buy Rating
MT
BTIG Starts Outlook Therapeutics at Buy With $7 Price Target
MT
Chardan Capital Starts Outlook Therapeutics at Buy With $10 Price Target
MT
Ascendiant Capital Adjusts Price Target on Outlook Therapeutics to $7.25 From $7, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. OTLK Stock
  4. Stock
  5. News OUTLOOK THERAPEUTICS, INC.
  6. Analyst Reco.